 SPARTA, N.J., Nov. 22, 2021 GLOBE NEWSWIRE -- PLx Pharma Inc. NASDAQ: PLXP PLx or the Company is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuardTM that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products VAZALORETM 325 mg and VAZALORETM 81 mg liquid-filled aspirin capsules referred to together as VAZALORE, announced today that Natasha Giordano, President and Chief Executive Officer, and Rita OConnor, Chief Financial Officer, are scheduled to present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021. 